The Izumi Lab aims to elucidate the molecular mechanism of pediatric neurodevelopmental genetic disorders toward the goals of identifying key pathways/molecules that can be used as therapeutic targets in these diagnoses.
Improving the safety, quality, and health outcomes of pediatric care through clinical research. PeRC’s mission is to provide the expertise and infrastructure needed to support research within the primary care setting.
Researchers have identified a gene mutation that causes developmental delay, intellectual disability, behavioral abnormalities and musculoskeletal problems in children.
Welcome back to another weekly edition of our roundup of research news from The Children's Hospital of Philadelphia! One of the things that is so exciting about research at CHOP is that our researchers are working to improve the health and lives of children in such a broad range of ways.
Half of infants born with severe congenital heart disease go on to develop neurodevelopmental disorders, which may include cognitive, motor, social, and language impairments.
By underscoring the importance of standardized childhood developmental screening and communication between clinicians and caregivers, two new studies from CHOP's PolicyLab can help physicians and families better support children with developmental